News 2012

Shareholders unanimously approved all proposals of the Board at the AGM

more

New Venturetec Annual Press Release 2012

more

Schedule for the Annual Shareholders Meeting 2012

more

New Venturetec: Result expectation 2011/12

more

Osiris: Interim Phase II results on Prochymal's Acute myocardial infarction trial

more

Osiris receives second approval for Prochymal by New Zealand

more

Osiris receives marketing clearance from Health Canada for Prochymal

more

New Venturetec Semi-Annual Results 2012

more

New Venturetec Results expectation for the first half of the fiscal year 2011/21

more